Researcher holding an Ananda organ-on-a-chip microplate over neuronal imagery

Human-Relevant Platforms
for Predictive Discovery

At Ananda Devices, we develop human-relevant organ-on-a-chip systems that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act.

Browse Our Case Studies

Trusted by

Numerous Pharma, Biotech & Governmental Institutions

Worldwide

Why ResearchersTrustAnanda

At Ananda Devices, we're redefining preclinical testing to reflect real human biology. With more than 99% of neurological drugs failing in clinical trials, the industry needs a better way.

Human-Relevant, Translational Platforms

Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.

Aligned with Regulators & Industry Leaders

Collaborating with leading pharmaceutical organizations and the U.S. FDA to advance regulatory-aligned, human-relevant testing strategies.

Scalable & Ethically Compliant

Ready-to-run, scalable human biology platforms that reduce reliance on animal models while supporting global 3Rs initiatives.

Multiparametric, Real-Time Insights

Continuously monitor neuronal and neuromuscular networks—capturing structure, function, connectivity, and treatment response over time, including countermeasure development of drug or toxin effects.

Ananda's TechnologyNeuroHTSTM

High-Throughput Human Neuronal Networks

NeuroHTS™ provides precisely organized networks for improved neuronal connectively, morphology and function - all in one assay. Advantages include precisely organized neuronal networks for reproducible screening, multiparametric high-throughput workflows, compatibility with primary & iPSC-derived neurons, and ideal applicability for neurotoxicity, regeneration & CNS drug discovery.

NeuroHTS microplate device from Ananda DevicesNeuroMuscle microplate device from Ananda Devices

Built with
Our Partners

25
Total Awards
1B+
Neurons analyzed
20+
Years Experience

We collaborate with pharmaceutical, biotechnology, Government and academic innovators to accelerate translational research and generate predictive human data that strengthens early development decisions.

We provide the tools for partners advance studies with greater reproducibility, scalability, and translational relevance.

Explore More Collaborations
UCB Pharma and Ananda Devices

Collaboration with UCB Pharma

Patient-derived neuromuscular models supporting Myasthenia Gravis drug-development decisions.

See Details
U.S. Food & Drug Administration and Ananda Devices

Partnership with the U.S. FDA

Supporting qualification of our platform as a NAM drug development tool and toxin testing.

See Details

Redefining
Preclinical Testing
with Human Biology

Founded in 2015, Ananda Devices builds human-relevant organ-on-a-chip platforms that enable predictive, scalable, and ethical preclinical testing beyond animal models.

Explore More Collaborations
Audience watching the Ananda Devices talk on reproducibility

Building Reproducibility into Preclinical Science

White laboratory mouse, illustrating the shift away from animal models
ReproducibilityStandardization

Canada Advances National Strategy for NAM Adoption

Jun 25, 2025  •  By Allan Ren

The challenge in neuroscience is the lack of access to human neural tissue, and the historical reliance on animal models. Biological standardization with human data is critically needed.

Read More

Bring human-relevant insights to your drug pipeline today!

Learn how Ananda's solutions support decisions across drug discovery, toxicology, and translational research.

Have a general inquiry? Email us directly at contact@anandadevices.com